Pituitary Adenylate Cyclase-activating Polypeptide (PACAP) -derived Peptide MPAPO Stimulates Adipogenic Differentiation by Regulating the Early Stage of Adipogenesis and ERK Signaling Pathway
Authors:
- 16 September 2022
- journal article
- research article
- Published by Springer Nature in Stem Cell Reviews and Reports
- Vol. 19 (2) , 516-530
Abstract
Regenerative medicine and tissue engineering have delivered new healing possibilities to the treatment of soft tissue defects, but the selection of seed cells is critical for treatment. Adipose-derived stem cells have perpetually been a preferred candidate for seed cells due to their wealthy sources, simple access, high plasticity, and powerful value-added capabilities. How to improve the efficiency of adipogenic differentiation is the key to the treatment. Pituitary adenylate cyclase-activating peptide, as a biologically active peptide secreted by the pituitary, is widely involved in regulating the body’s sugar metabolism and lipid metabolism. However, the effects of MPAPO in ADSCs adipogenic differentiation remain unknown. Our results reveal that MPAPO treatment improves the adipogenic differentiation efficiency of ADSCs, including promoting the accumulation of lipid droplets and triglycerides, and the expression of adipocyte protein biomarkers PPARγ and C/EBPa. Additionally, the mechanism studies showed that the effective window of MPAPO-induced adipogenesis was the first 3 days during ADSCs differentiation. MPAPO selectively binds to the PAC1 receptor and promotes adipogenic differentiation of ADSCs by activating the ERK signaling pathway and elevating cell proliferation during postconfluent mitosis stage. Altogether, we demonstrate that MPAPO plays a crucial role in ADSCs adipogenesis, providing experimental basis and data for exploring therapeutic options in tissue defect repair. Graphical AbstractKeywords
Funding Information
- National Natural Science Foundation of China (82073748, 81741130)
This publication has 56 references indexed in Scilit:
- Pituitary Adenylate Cyclase Activating Peptide (PACAP) Participates in Adipogenesis by Activating ERK Signaling PathwayPLOS ONE, 2013
- Role of Mitogen-Activated Protein Kinase Pathways in Multifactorial Adverse Cardiac Remodeling Associated with Metabolic SyndromeMediators of Inflammation, 2013
- Aristolochia Manshuriensis Kom Inhibits Adipocyte Differentiation by Regulation of ERK1/2 and Akt PathwayPLOS ONE, 2012
- MicroRNA‐375 promotes 3T3‐L1 adipocyte differentiation through modulation of extracellular signal‐regulated kinase signallingClinical and Experimental Pharmacology and Physiology, 2011
- The Adipose-derived Stem Cell: Looking Back and Looking AheadMolecular Biology of the Cell, 2010
- White Fat Progenitor Cells Reside in the Adipose VasculatureScience, 2008
- Feeding and Metabolism in Mice Lacking Pituitary Adenylate Cyclase-Activating PolypeptideEndocrinology, 2007
- Adipocytes as regulators of energy balance and glucose homeostasisNature, 2006
- Stable stem cell commitment to the adipocyte lineage by inhibition of DNA methylation: Role of the BMP-4 geneProceedings of the National Academy of Sciences, 2006
- Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based TherapiesTissue Engineering, 2001